𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Generation and characterization of a single-gene mouse–human chimeric antibody against hepatitis B surface antigen

✍ Scribed by Biplab Bose; Navin Khanna; Subrat K Acharya; Subrata Sinha

Book ID
108950810
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
241 KB
Volume
0
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Production and characterization of a mou
Production and characterization of a mouse/human chimeric antibody directed against human neuroblastoma
✍ H. Amstutz; Ch. Rytz; I. Novak-Hofer; M. Spycher; P. A. Schubiger; K. Blaser; J. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 744 KB

## Abstract Hybridoma CE7 produces a murine antibody (yl/k) which binds to a 190‐kDa cell‐surface glycoprotein of human neuroblas‐toma. Because of its tumor specificity, it has been used routinely in clinical pathology to confirm diagnosis of neuroblastoma. We have Isolated the gene segments coding

Characterization of a mouse-human chimer
Characterization of a mouse-human chimeric antibody to a cancer-associated antigen
✍ R. Orlandi; M. Figini; A. Tomassetti; S. Canevari; M. I. Colnaghi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 639 KB

In an attempt to obtain a therapeutic antibody, the murine monoclonal antibody (MAb) MBr I (IgM,k), directed against human carcinomas, was converted in a mouse/human chimeric MAb of y l isotype. The chimeric MAb, y l CHI-MBrl, retains the ability to specifically bind tumor cells and tissues with no

Bacterial expression of a human recombin
Bacterial expression of a human recombinant monoclonal antibody Fab fragment against hepatitis B surface antigen
✍ Maeda, F.; Nagatsuka, Y.; Ihara, S.; Aotsuka, S.; Ono, Y.; Inoko, H.; Takekoshi, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

The Fab fragment was cloned from the monoclonal cell line TAPC301-CL4, which was produced using the Epstein-Barr virus (EBV) transformation method. This cell line produces a human monoclonal antibody (CL4MAb) against the hepatitis B surface antigen (HBsAg). This MAb was shown to have hepatitis B vir